5-[(2,5-dimethylphenoxy)methyl]-4-ethyl-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

2-Chloroethyl4-nitrophenylether, 95.0%, 10g

2-Amino-4-bromothiazole, 95.0%, 5g

Benzyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate, 95.0%, 1g

Objectif Plan PLPOLi 60x/0,85 IOS sans contrainte pour polarisation transmise iScope, correction du verre de protection de 0,17 mm, distance de travail de 0,14 mm

5-Methyl-1-(4-methylbenzyl)-1H-1,2,3-triazol-4-amine, 95+%, 50mg

(3-Fluoro-4-(phenylcarbamoyl)phenyl)boronic acid, 95.0%, 1g

oxo(3-pyridinyl)acetic acid hydrate, 95.0%, 1g

6-Bromo-3-chloropyrazin-2-amine, 95.0%, 250mg

1-(3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl)-3-(methylthio)propan-1-amine oxalate, 95.0%, 1g

3,4-Bis((((9H-fluoren-9-yl)methoxy)carbonyl)amino)benzoic acid, 97%, 10g

2-cyano-N-(4-methoxyphenyl)acetamide, 25g

1-Isopropyl-3-methoxybenzene, 98.0%, 25g